More on CYCN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)

Upcoming Events

- Earnings (11/5/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Cyclerion Therapeutics (NQ:CYCN)
Delayed: 1.41 +0.02 (1.44%)
Prev. Close $1.39  
Open$1.32 
52 Wk High$ 
52 Wk Low$ 
Day High$1.44 
Day Low$1.31 
P/E N/A  
EPS$ 
Volume26,168 

Friends, Peers and Foes (?): ALMS BFRG (more...)

Feb 17, 2026 07:22 AM Form 8-K Cyclerion Therapeutics, For: Feb 17
Feb 17, 2026 07:00 AM Cyclerion receives FDA feedback on depression treatment study
Feb 17, 2026 07:00 AM Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
Jan 6, 2026 09:31 AM Morning Market Brief: Breakthrough Biology Meets Scalable Platforms as Innovators Surge into Focus
Jan 6, 2026 08:34 AM Form 8-K Cyclerion Therapeutics, For: Jan 03
Jan 5, 2026 04:01 PM Cyclerion partners with Medsteer for depression treatment development
Jan 5, 2026 04:01 PM Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
Dec 1, 2025 05:13 PM Form 8-K Cyclerion Therapeutics, For: Dec 01
Nov 12, 2025 04:31 PM Form 10-Q Cyclerion Therapeutics, For: Sep 30
Nov 12, 2025 04:16 PM Form 10-K/A Cyclerion Therapeutics, For: Dec 31
View All Articles

Entities mentioned with CYCN

View All Entities